| Ping Zhang |
GYRE |
Stock Option (Right to Buy) |
Award |
|
|
|
100,000 |
100,000 |
07 Jan 2026 |
Direct |
| Ruoyu Chen |
GYRE |
Stock Option (Right to Buy) |
Award |
|
|
|
50,000 |
50,000 |
07 Jan 2026 |
Direct |
| Dan Weng |
GYRE |
Stock Option (Right to Buy) |
Award |
|
|
|
52,000 |
52,000 |
18 Aug 2025 |
Direct |
| Ping Zhang |
GYRE |
Stock Option (Right to Buy) |
Award |
|
|
|
250,000 |
250,000 |
05 Aug 2025 |
Direct |
| Thomas Wilson Eastling |
GYRE |
Stock Option (Right to Buy) |
Award |
|
|
|
26,000 |
26,000 |
04 Jun 2025 |
Direct |
| David M. Epstein |
GYRE |
Stock Option (Right to Buy) |
Award |
|
|
|
26,000 |
26,000 |
04 Jun 2025 |
Direct |
| Rodney L. Nussbaum |
GYRE |
Stock Option (Right to Buy) |
Award |
|
|
|
26,000 |
26,000 |
04 Jun 2025 |
Direct |
| Renate Parry |
GYRE |
Stock Option (Right to Buy) |
Award |
|
|
|
26,000 |
26,000 |
04 Jun 2025 |
Direct |
| Gordon Carmichael |
GYRE |
Stock Option (Right to Buy) |
Award |
|
|
|
26,000 |
26,000 |
04 Jun 2025 |
Direct |
| Songjiang Ma |
GYRE |
Common Stock |
Sale |
-0.02% |
$5,619 |
$10.07 |
-558 |
2,806,084 |
28 May 2025 |
By Spouse |
| Songjiang Ma |
GYRE |
Common Stock |
Sale |
-0.07% |
$20,560 |
$10.28 |
-2,000 |
2,806,642 |
27 May 2025 |
By Spouse |
| Ping Zhang |
GYRE |
Stock Option (Right to Buy) |
Award |
|
|
|
250,000 |
250,000 |
27 May 2025 |
Direct |
| Songjiang Ma |
GYRE |
Common Stock |
Sale |
-0.01% |
$1,864 |
$10.24 |
-182 |
2,808,642 |
23 May 2025 |
By Spouse |
| Songjiang Ma |
GYRE |
Common Stock |
Sale |
-0.07% |
$21,940 |
$10.97 |
-2,000 |
2,808,824 |
22 May 2025 |
By Spouse |
| Songjiang Ma |
GYRE |
Common Stock |
Sale |
-0.07% |
$21,660 |
$10.83 |
-2,000 |
2,810,824 |
21 May 2025 |
By Spouse |
| Songjiang Ma |
GYRE |
Common Stock |
Sale |
-0.07% |
$22,500 |
$11.25 |
-2,000 |
2,812,824 |
20 May 2025 |
By Spouse |
| Songjiang Ma |
GYRE |
Common Stock |
Sale |
-0.07% |
$22,220 |
$11.11 |
-2,000 |
2,814,824 |
19 May 2025 |
By Spouse |
| Songjiang Ma |
GYRE |
Common Stock |
Sale |
-0.07% |
$22,620 |
$11.31 |
-2,000 |
2,816,824 |
16 May 2025 |
By Spouse |
| Songjiang Ma |
GYRE |
Common Stock |
Sale |
-0.07% |
$21,360 |
$10.68 |
-2,000 |
2,818,824 |
15 May 2025 |
By Spouse |
| Songjiang Ma |
GYRE |
Common Stock |
Sale |
|
$226 |
$11.30 |
-20 |
2,820,824 |
14 May 2025 |
By Spouse |
| Songjiang Ma |
GYRE |
Common Stock |
Sale |
-0.07% |
$22,740 |
$11.37 |
-2,000 |
2,820,844 |
13 May 2025 |
By Spouse |
| Songjiang Ma |
GYRE |
Common Stock |
Sale |
-0.07% |
$21,120 |
$10.56 |
-2,000 |
2,822,844 |
12 May 2025 |
By Spouse |
| Thomas Wilson Eastling |
GYRE |
Common Stock |
Options Exercise |
|
|
|
15,000 |
15,000 |
16 Apr 2025 |
Direct |
| Thomas Wilson Eastling |
GYRE |
Stock Option (Right to Buy) |
Options Exercise |
-4.77% |
|
|
-15,000 |
299,652 |
16 Apr 2025 |
Direct |
| Weiguo Ye |
GYRE |
Common Stock |
Options Exercise |
7.69% |
|
|
50,000 |
700,000 |
01 Apr 2025 |
Direct |
| Weiguo Ye |
GYRE |
Stock Option (Right to Buy) |
Options Exercise |
-4.93% |
|
|
-50,000 |
965,115 |
01 Apr 2025 |
Direct |
| Weiguo Ye |
GYRE |
Common Stock |
Options Exercise |
30% |
|
|
150,000 |
650,000 |
27 Mar 2025 |
Direct |
| Weiguo Ye |
GYRE |
Stock Option (Right to Buy) |
Options Exercise |
-12.9% |
|
|
-150,000 |
1,015,115 |
27 Mar 2025 |
Direct |
| Weiguo Ye |
GYRE |
Common Stock |
Options Exercise |
66.7% |
|
|
200,000 |
500,000 |
26 Mar 2025 |
Direct |
| Weiguo Ye |
GYRE |
Stock Option (Right to Buy) |
Options Exercise |
-14.6% |
|
|
-200,000 |
1,165,115 |
26 Mar 2025 |
Direct |
| Weiguo Ye |
GYRE |
Common Stock |
Options Exercise |
|
|
|
300,000 |
300,000 |
24 Mar 2025 |
Direct |
| Weiguo Ye |
GYRE |
Stock Option (Right to Buy) |
Options Exercise |
-18% |
|
|
-300,000 |
1,365,115 |
24 Mar 2025 |
Direct |
| Songjiang Ma |
GYRE |
Common Stock |
Sale |
-0.01% |
$1,740 |
$10.00 |
-174 |
2,824,844 |
21 Mar 2025 |
By Spouse |
| Songjiang Ma |
GYRE |
Common Stock |
Sale |
-0.07% |
$20,180 |
$10.09 |
-2,000 |
2,825,018 |
20 Mar 2025 |
By Spouse |
| Songjiang Ma |
GYRE |
Common Stock |
Sale |
-0.07% |
$20,260 |
$10.13 |
-2,000 |
2,827,018 |
19 Mar 2025 |
By Spouse |
| Songjiang Ma |
GYRE |
Common Stock |
Sale |
-0.01% |
$2,478 |
$10.24 |
-242 |
2,829,018 |
18 Mar 2025 |
By Spouse |
| Songjiang Ma |
GYRE |
Common Stock |
Sale |
-0.07% |
$24,180 |
$12.09 |
-2,000 |
2,829,260 |
17 Mar 2025 |
By Spouse |
| Songjiang Ma |
GYRE |
Common Stock |
Sale |
-0.07% |
$24,620 |
$12.31 |
-2,000 |
2,831,260 |
14 Mar 2025 |
By Spouse |
| Songjiang Ma |
GYRE |
Common Stock |
Sale |
-0.07% |
$23,600 |
$11.80 |
-2,000 |
2,833,260 |
13 Mar 2025 |
By Spouse |
| Songjiang Ma |
GYRE |
Common Stock |
Sale |
-0.07% |
$23,480 |
$11.74 |
-2,000 |
2,835,260 |
12 Mar 2025 |
By Spouse |
| Songjiang Ma |
GYRE |
Common Stock |
Sale |
-0.07% |
$22,800 |
$11.40 |
-2,000 |
2,837,260 |
11 Mar 2025 |
By Spouse |
| Songjiang Ma |
GYRE |
Common Stock |
Sale |
-0.07% |
$20,280 |
$10.14 |
-2,000 |
2,839,260 |
10 Mar 2025 |
By Spouse |
| Weiguo Ye |
GYRE |
Stock Option (Right to Buy) |
Award |
|
|
|
300,000 |
300,000 |
07 Mar 2025 |
Direct |
| Songjiang Ma |
GYRE |
Common Stock |
Sale |
-0.07% |
$20,496 |
$10.25 |
-2,000 |
2,841,260 |
07 Mar 2025 |
By Spouse |
| Songjiang Ma |
GYRE |
Common Stock |
Sale |
-0.07% |
$21,600 |
$10.80 |
-2,000 |
2,843,260 |
06 Mar 2025 |
By Spouse |
| Songjiang Ma |
GYRE |
Common Stock |
Sale |
-0.07% |
$21,960 |
$10.98 |
-2,000 |
2,845,260 |
05 Mar 2025 |
By Spouse |
| Songjiang Ma |
GYRE |
Common Stock |
Sale |
-0.07% |
$21,720 |
$10.86 |
-2,000 |
2,847,260 |
04 Mar 2025 |
By Spouse |
| Songjiang Ma |
GYRE |
Common Stock |
Sale |
-0.07% |
$22,460 |
$11.23 |
-2,000 |
2,849,260 |
03 Mar 2025 |
By Spouse |
| Songjiang Ma |
GYRE |
Common Stock |
Sale |
-0.07% |
$22,820 |
$11.41 |
-2,000 |
2,851,260 |
28 Feb 2025 |
By Spouse |
| Songjiang Ma |
GYRE |
Common Stock |
Sale |
-0.07% |
$22,660 |
$11.33 |
-2,000 |
2,853,260 |
27 Feb 2025 |
By Spouse |